Enimmune and Unicocell join forces to capture exosome market opportunities

Enimmune signed an agreement with Unicocell Biotechnology on June 25, partnering to develop exosome-based cosmetic products and further expand into the field of regenerative medicine. General Manager Che-Wei Chang stated that they will initially target Vietnam and Southeast Asian countries, where they already have a cooperation foundation, aiming to capture opportunities among the top-tier consumer segment.